Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization.

Narita M, Oussoultzoglou E, Chenard MP, Fuchshuber P, Rather M, Rosso E, Addeo P, Jaeck D, Bachellier P.

Ann Surg Oncol. 2012 Jul;19(7):2230-7. doi: 10.1245/s10434-011-2112-6. Epub 2012 Mar 9.

PMID:
22402811
2.

Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.

Soubrane O, Brouquet A, Zalinski S, Terris B, Brézault C, Mallet V, Goldwasser F, Scatton O.

Ann Surg. 2010 Mar;251(3):454-60. doi: 10.1097/SLA.0b013e3181c79403.

PMID:
20160638
3.

Evaluation of the usefulness of the indocyanine green clearance test for chemotherapy-associated liver injury in patients with colorectal cancer liver metastasis.

Wakiya T, Kudo D, Toyoki Y, Ishido K, Kimura N, Narumi S, Kijima H, Hakamada K.

Ann Surg Oncol. 2014 Jan;21(1):167-72.

PMID:
23959055
4.

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, Bachellier P, Jaeck D.

Ann Surg. 2008 Jan;247(1):118-24.

PMID:
18156931
5.

Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.

Viganò L, Capussotti L, De Rosa G, De Saussure WO, Mentha G, Rubbia-Brandt L.

Ann Surg. 2013 Nov;258(5):731-40; discussion 741-2. doi: 10.1097/SLA.0b013e3182a6183e.

PMID:
24045448
6.

[Influence of pre-surgical chemotherapy on liver parenchyma and post-surgical outcome of patients subjected to hepatectomy due to colorectal carcinoma metastases].

Gómez-Ramírez J, Martín-Pérez E, Amat CG, Sanz IG, Bermejo E, Rodríguez A, Larrañaga E.

Cir Esp. 2010 Dec;88(6):404-12. doi: 10.1016/j.ciresp.2010.09.005. Epub 2010 Oct 23. Spanish.

7.

Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases.

Khan AZ, Morris-Stiff G, Makuuchi M.

J Hepatobiliary Pancreat Surg. 2009;16(2):137-44. doi: 10.1007/s00534-008-0016-z. Epub 2008 Dec 18. Review.

PMID:
19093069
8.

Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.

Vreuls CP, Van Den Broek MA, Winstanley A, Koek GH, Wisse E, Dejong CH, Olde Damink SW, Bosman FT, Driessen A.

Histopathology. 2012 Aug;61(2):314-8. doi: 10.1111/j.1365-2559.2012.04208.x. Epub 2012 May 9.

PMID:
22571348
9.

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B.

Ann Oncol. 2004 Mar;15(3):460-6.

10.

Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.

Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, Gruenberger T.

Ann Surg Oncol. 2011 Feb;18(2):421-30. doi: 10.1245/s10434-010-1317-4. Epub 2010 Sep 16.

PMID:
20844968
11.

Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases.

van den Broek MA, Vreuls CP, Winstanley A, Jansen RL, van Bijnen AA, Dello SA, Bemelmans MH, Dejong CH, Driessen A, Olde Damink SW.

Ann Surg Oncol. 2013 May;20(5):1462-9. doi: 10.1245/s10434-013-2915-8. Epub 2013 Mar 6.

PMID:
23463086
12.

A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.

Narita M, Hatano E, Ikai I, Miyagawa-Hayashino A, Yanagida A, Nagata H, Asechi H, Taura K, Uemoto S.

Ann Surg. 2009 May;249(5):806-13. doi: 10.1097/SLA.0b013e3181a38ed5.

PMID:
19387321
13.

Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing.

Krieger PM, Tamandl D, Herberger B, Faybik P, Fleischmann E, Maresch J, Gruenberger T.

Ann Surg Oncol. 2011 Jun;18(6):1644-50. doi: 10.1245/s10434-010-1494-1. Epub 2011 Jan 5.

PMID:
21207168
14.

Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases.

Morris-Stiff G, Tan YM, Vauthey JN.

Eur J Surg Oncol. 2008 Jun;34(6):609-14. Epub 2007 Aug 30. Review.

PMID:
17764887
15.

Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients.

Komori H, Beppu T, Baba Y, Horino K, Imsung C, Masuda T, Hayashi H, Okabe H, Ootao R, Watanabe M, Takamori H, Iyama K, Baba H.

Int J Clin Oncol. 2010 Jun;15(3):263-70. doi: 10.1007/s10147-010-0046-9. Epub 2010 Mar 19.

PMID:
20238233
16.

Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.

Morris-Stiff G, White AD, Gomez D, Cameron IC, Farid S, Toogood GJ, Lodge JP, Prasad KR.

Eur J Surg Oncol. 2014 Aug;40(8):1016-20. doi: 10.1016/j.ejso.2013.09.015. Epub 2013 Nov 1.

PMID:
24370284
17.

What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy?

Narita M, Oussoultzoglou E, Fuchshuber P, Pessaux P, Chenard MP, Rosso E, Nobili C, Jaeck D, Bachellier P.

Ann Surg Oncol. 2012 Aug;19(8):2526-38. doi: 10.1245/s10434-012-2274-x. Epub 2012 Mar 7.

PMID:
22395987
18.

Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.

Wolf PS, Park JO, Bao F, Allen PJ, DeMatteo RP, Fong Y, Jarnagin WR, Kingham TP, Gönen M, Kemeny N, Shia J, D'Angelica MI.

J Am Coll Surg. 2013 Jan;216(1):41-9. doi: 10.1016/j.jamcollsurg.2012.08.030. Epub 2012 Oct 5.

PMID:
23041049
19.

Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome.

Imai K, Emi Y, Iyama KI, Beppu T, Ogata Y, Kakeji Y, Samura H, Oki E, Akagi Y, Maehara Y, Baba H; Kyusyu Study Group of Clinical Cancer (KSCC) ancillary study.

Eur J Surg Oncol. 2014 May;40(5):559-66. doi: 10.1016/j.ejso.2013.12.009. Epub 2013 Dec 20.

PMID:
24388740
20.

Consequences of chemotherapy on resection of colorectal liver metastases.

Pessaux P, Chenard MP, Bachellier P, Jaeck D.

J Visc Surg. 2010 Aug;147(4):e193-201. doi: 10.1016/j.jviscsurg.2010.06.004. Epub 2010 Jul 23. Review.

PMID:
20655821
Items per page

Supplemental Content

Write to the Help Desk